Wird geladen...

NRF2-Dependent Bioactivation of Mitomycin C as a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer

Activating mutations in the KEAP1-NRF2 pathway are found in approximately 25% of lung tumors, where the hijacking of NRF2’s cytoprotective functions results in aggressive tumor growth, chemoresistance, and a poor prognosis for patients. There are currently no approved drugs which target aberrant NRF...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mol Cell Biol
Hauptverfasser: Baird, Liam, Yamamoto, Masayuki
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2021
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8093492/
https://ncbi.nlm.nih.gov/pubmed/33139492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/MCB.00473-20
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!